Product Information
ERYTHROMYCIN 200 MG/5 ML SUSP is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $1.5305 per ML under NDC 62559044002. Its NADAC has been published 175 times since Sep 23, 2020.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/5mL
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559044002
Classification
Generic
Dosage Form
GRANULE, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ERYTHROMYCIN ETHYLSUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA062055FDA Approved
Before 1982
TE Code
AB
On Market Since
9/27/2016
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN 200 MG/5 ML SUSP has been published 175 times since Sep 23, 2020, and over the history we have for it it has declined 40.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5305 per ML |
|---|---|
| All-time high | $2.5796 (Sep 15, 2021) |
| All-time low | $1.1184 (Nov 20, 2024) |
| 52-week high | $1.6022 |
| 52-week low | $1.3452 |
| Median price | $1.4781 |
| Average price | $1.7329 |
| Largest weekly change | -51.8% (Apr 17, 2024) |
| Weeks tracked | 175 |
| Tracking since | Sep 23, 2020 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 40% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN 200 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 200 MG/5 ML SUSP, manufactured by ANI Pharmaceuticals, Inc., is $1.5305 per ML (NDC 62559044002), effective Aug 19, 2026.
How has the price of ERYTHROMYCIN 200 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN 200 MG/5 ML SUSP has declined 40.7%. It has been tracked across 175 weekly CMS publications since Sep 23, 2020.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 200 MG/5 ML SUSP?
Since Sep 23, 2020, the NADAC for ERYTHROMYCIN 200 MG/5 ML SUSP has ranged from a low of $1.1184 (Nov 20, 2024) to a high of $2.5796 (Sep 15, 2021), with a median of $1.4781 per ML.
Are there cheaper alternatives to ERYTHROMYCIN 200 MG/5 ML SUSP?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERYTHROMYCIN 200 MG/5 ML SUSP, is $0.9144 per ML — about 40% below ERYTHROMYCIN 200 MG/5 ML SUSP.
Who manufactures ERYTHROMYCIN 200 MG/5 ML SUSP?
ERYTHROMYCIN 200 MG/5 ML SUSP (NDC 62559044002) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.